Circulating cell-derived microparticles in patients with mild obstructive steep apnoea

Circulating cell-derived microparticles in patients with mild obstructive steep apnoea

Bibliographic Details
Main Authors:	Ayers, L, Ferry, B, Craig, S, Nicoll, D, Stradling, J, Kohler, M
Format:	Conference item
Published:	2008

Similar Items

Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
by: Ayers, L, et al.
Published: (2009)

Circulating Cell-Derived Microparticles in Patients with Minimally Symptomatic Obstructive Sleep Apnea
by: Kohler, M, et al.
Published: (2009)

Endothelial function in patients with mild moderate obstructive sleep apnoea
by: Kohler, M, et al.
Published: (2007)

Withdrawal of continuous positive airway pressure therapy for 2 weeks in obstructive sleep apnoea patients results in increased circulating platelet and leucocyte-derived microvesicles
by: Ayers, L, et al.
Published: (2016)

Withdrawal of Continuous Positive Airway Pressure Therapy for 2 Weeks in Obstructive Sleep Apnoea Patients Results in Increased Circulating Platelet and Leucocyte-Derived Microvesicles.
by: Ayers, L, et al.
Published: (2016)

Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
by: Schulz, U, et al.
Published: (2013)

Elevated levels of endothelial cell-derived microparticles following short-term withdrawal of continuous positive airway pressure in patients with obstructive sleep apnea: Data from a randomized controlled trial
by: Ayers, L, et al.
Published: (2013)

Elevated levels of endothelial cell-derived microparticles following short-term withdrawal of continuous positive airway pressure in patients with obstructive sleep apnea: data from a randomized controlled trial.
by: Ayers, L, et al.
Published: (2013)

Prevalence of obstructive sleep apnoea in men with type 2 diabetes.
by: West, S, et al.
Published: (2006)

The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: A randomised controlled trial.
by: West, S, et al.
Published: (2009)

Mild To Moderate, Minimally Symptomatic, Obstructive Sleep Apnoea (OSA) Is Associated With 'Vulnerable' Carotid Atherosclerotic Plaques
by: Craig, SE, et al.
Published: (2010)

Obstructive sleep apnoea.
by: Stradling, J
Published: (2007)

Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
by: Ayers, L, et al.
Published: (2011)

Effects of obstructive sleep apnoea on heart rhythm.
by: Rossi, V, et al.
Published: (2013)

Pharmacological approaches to the treatment of obstructive sleep apnoea.
by: Kohler, M, et al.
Published: (2009)

Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial.
by: Kohler, M, et al.
Published: (2009)

The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
by: Kohler, M, et al.
Published: (2007)

The phenotype of obstructive sleep apnoea
by: Stradling, J
Published: (2008)

Driving and obstructive sleep apnoea.
by: Stradling, J
Published: (2008)

Obstructive sleep apnoea syndrome.
by: Stradling, JR
Published: (1982)

Obstructive sleep apnoea and driving.
by: Stradling, JR
Published: (1989)

Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
by: Turnbull, C, et al.
Published: (2019)

Prevalence of Retinopathy in Men with Type 2 Diabetes and Obstructive Sleep Apnoea.
by: West, S, et al.
Published: (2009)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
by: Craig, SE, et al.
Published: (2012)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
by: Craig, SE, et al.
Published: (2012)

Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions.
by: Kohler, M, et al.
Published: (2011)

Obstructive sleep apnoea in adults.
by: West, S, et al.
Published: (2009)

Night-to-night variability of obstructive sleep apnoea
by: Stoberl, A, et al.
Published: (2017)

The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea.
by: West, S, et al.
Published: (2010)

TWO YEAR VASCULAR EVENT, HOSPITAL ADMISSIONS, AND ACCIDENT INCIDENCE: FURTHER DATA FROM THE MOSAIC SLEEP APNOEA TRIAL
by: Turnbull, C, et al.
Published: (2012)

Acute effects of obstructive sleep apnoea.
by: Davies, R, et al.
Published: (1993)

Obstructive sleep apnoea - Reply
by: Stradling, JR, et al.
Published: (1999)

Obstructive sleep apnoea: is it moving into primary care?
by: Stradling, J
Published: (2016)

Systemic hypertension and obstructive sleep apnoea.
by: Pepperell, J, et al.
Published: (2002)

In Patients with Obstructive Sleep Apnoea Oxygen Desaturation Index (ODI) Is Associated with Aortic Distensibility and Atheroma Burden.
by: Craig, SE, et al.
Published: (2009)

Physiological consequences of CPAP therapy withdrawal in patients with obstructive sleep apnoea-An opportunity for an efficient experimental model
by: Schwarz, E, et al.
Published: (2018)

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes.
by: West, S, et al.
Published: (2007)

Easily Missed? Obstructive sleep apnoea in adults
by: West, S, et al.
Published: (2009)

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.
by: Robinson, G, et al.
Published: (2004)

Is continuous positive airway pressure necessarily an everyday therapy in patients with obstructive sleep apnoea?
by: Rossi, V, et al.
Published: (2014)